Stockreport

Ocuphire Pharma Announces Acquisition of Opus Genetics

Ocuphire Pharma, Inc.  (OCUP) 
PDF Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations New OPGx-LCA5 Phase [Read more]